Pet Drug Reports

Amitraz: adverse event reports in all combinations

Active ingredient, alone and in combinations

Brand names with this ingredient: Mitaban.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Read this first. FDA says this about the data:

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .

This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.

Contacting a veterinarianHow to report to FDA

FDA reports received through . Counts include this ingredient alone and in combinations. Why brand names have no separate count.

From February 1987 to March 2023, FDA received 1,567 adverse event reports that name a drug with amitraz, alone or in a combination. 2 sets of active ingredients with amitraz have a drug page.

Of the 1,567 reports, 1,320 (84.2%) are about dogs. 131 reports are about people who were exposed to the drug (8.4%). In January to March 2026, FDA received no reports that name amitraz, alone or in a combination. The signs that appear in the largest number of the 1,567 reports are "Lethargy", "Depression" and "Vomiting". A report is not proof that a drug caused a sign.

Fewer than 20 reports named this ingredient in the 12 months before June 2026, so this page gives no change. Reports about dogs are 84.2% of the reports that name this ingredient, and 72.6% of all reports.

Search engines list an ingredient page with 500 reports or more in all years. The page also needs 30 reports or more in the 12 months to June 2026. This page is under one of these numbers. The site keeps the page and keeps it out of search engines.

Reports in the latest closed quarter

Reports that name amitraz, by the quarter in which FDA received them
SpeciesJan to Mar 2026Oct to Dec 2025Jan to Mar 2025
All species000
Dog000
Cat000
Horse000
Other or not given000

January to March 2026 is the latest closed quarter in the data.

All updatesFeed of updates (RSS)

Drug pages with amitraz

A report names a drug by its set of active ingredients. Each set with amitraz that has a drug page is in the table, in order of name. The table has 2 sets.

Drug pages with amitraz, in order of name, with the reports of each page
Active ingredientsReports, all yearsReports, latest 12 months
Amitraz1,1050
Amitraz + (S) - methoprene4620

A report can name more than one set, so the counts of the sets can add to more than the count of the page.

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

Signs that the reports list

A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 1,567 reports that list the sign. One report can list more than one sign and more than one drug.

The sign that is in the largest number of the reports comes first.

  1. Lethargy[unusually tired or inactive]21.9%343 reports
  2. Depression[dull, quiet or withdrawn]17.8%279 reports
  3. Vomiting15.4%241 reports
  4. Ataxia[unsteady, uncoordinated movement]8.8%138 reports
  5. Anorexia[not eating]6.6%103 reports
  6. Unclassifiable adverse event[event that fits no dictionary term]6.5%102 reports
  7. Diarrhoea[diarrhea]6.1%96 reports
  8. Death5.5%86 reports
  9. Lack of efficacy (ectoparasite) - Demodex[the product did not have the expected effect: Demodex]5.3%83 reports
  10. Accidental exposure[exposure that was not intended]5.1%80 reports
  11. Pruritus[itching]4.9%76 reports
  12. Vials, Leaking[a product quality report, not a sign in an animal]4.3%67 reports
  13. Sedation4.2%66 reports
  14. Convulsion[seizure]3.7%58 reports
Show the next 16 signs
  1. Behavioural disorder NOS[behaviour change, type not specified]3.3%52 reports
  2. Rash2.9%45 reports
  3. Bradycardia[slow heart rate]2.8%44 reports
  4. Skin hyperaemia[reddened skin]2.7%43 reports
  5. Emesis[vomiting]2.4%38 reports
  6. Fever2.4%38 reports
  7. Caps, Abnormal[a product quality report, not a sign in an animal]2.2%35 reports
  8. Weakness2%32 reports
  9. Seizure NOS[seizure, type not specified]1.9%30 reports
  10. Hypothermia[low body temperature]1.8%28 reports
  11. Aggression1.7%27 reports
  12. Hypersalivation[drooling]1.7%27 reports
  13. Application site irritation[irritation where the product was applied]1.7%26 reports
  14. Skin lesion NOS[NOS: not otherwise specified]1.6%25 reports
  15. Elevated serum alkaline phosphatase (SAP)[a liver and bone enzyme above the normal range]1.5%24 reports
  16. Other abnormal test result NOS[abnormal laboratory result, type not specified]1.5%24 reports

Download all signs (CSV)

Reports by species

  • Dog84.2%1,320
  • Human exposure8.4%131
  • Cat0.3%4
  • Other0.1%2
  • Other Canids0.1%2
  • Fish0.1%1

Reports for each month, Jul 2021 to Jun 2026

Dog3 reports

No chart: no month has 5 or more reports.

Cat0 reports

No chart: no month has 5 or more reports.

Horse0 reports

No chart: no month has 5 or more reports.

Other or not given1 report

No chart: no month has 5 or more reports.

The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

Reports by year

  • Dog
  • Cat
  • Horse
  • Other or not given
Reports that name amitraz, by the year in which FDA received them and by species
YearDogCatHorseOther or not givenAll species
202320002
202110012
201860028
20171100011
20161800220
20154600248
201469001584
20131790013192
20123510019370
20114800654
20104500954
20092600430
200843003174
200769101585
200677002198
200578201393
200454001165
2003800210
20022110830
20011300013
2000600915
19994001418
199814001731
1997900312
199650005
199550005
199490009
19931700825
19922000424
19911800018
19901800018
19891100516
1988900817
19871000111

2023 has the reports that FDA received through Mar 2023. Download the years (CSV)

What the reports record

Outcome at the time of the report

  • Recovered/Normal20.7%324
  • Recovered with Sequela[recovered, with a lasting effect]1%15
  • Ongoing6.1%95
  • Died6.4%101
  • Euthanized0.4%7
  • Outcome Unknown16%250

An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 1,567 reports that name amitraz.

Kind of report

  • Safety issue90%1,411
  • Lack of expected effectiveness0.9%14
  • Both safety and lack of expected effectiveness1.8%28
  • Manufacturing or product defect7.3%114
  • Other0%0

Age of the animal

  • Under 1 year29.4%461
  • 1 to 3 years22.7%356
  • 4 to 7 years13.8%216
  • 8 to 11 years9.1%142
  • 12 years and over6.1%96
  • Age not given18.9%296

Each share of kind and age is of the 1,567 reports that name amitraz.

Approved animal drugs with this active ingredient (FDA Green Book)

This section is reference data. It has no report count.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Brand names

  • Mitaban

What the Green Book records give

Applications with an approval in force
1
Approved species
Dogs
Dose forms
Liquid
Routes
Topical
Sale
RX (prescription)

The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.

Applications in the Green Book of 2 Nov 2026, pioneer applications (NADA) first
Brand nameActive ingredientsSponsorApproved speciesApplication
Mitaban Liquid ConcentrateAmitrazZoetis Inc.DogsNADA 120-299

FDA pages for this ingredient

The site checked these addresses on . The links open in a new tab.

Cite this page

Pet Drug Reports. Amitraz, all combinations: adverse event reports that FDA received. https://petdrugreports.com/ingredient/amitraz/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .

Where the data come from

The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. Ingredient names follow the Green Book, with salts and forms as FDA lists them.

The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.

Questions about these reports

Which brand are these reports about?

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists brand names with this active ingredient.

Do the reports show that the ingredient caused the signs?

No. A report can name more than one drug, and a drug can have more than one active ingredient. FDA states this about the data.

When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.

The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

How many reports did FDA receive in the latest 12 months?

FDA received no reports in the 12 months to June 2026. It received no reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

What kinds of report are in the count?

Of the 1,567 reports received from February 1987 to March 2023, 90% are about a safety issue only. 2.7% are about a lack of expected effectiveness, alone or with a safety issue. 7.3% are about a defect of the product or its package.